Comparison of Clinical Manifestations of Kawasaki Disease According to SARS-CoV-2 Antibody Positivity

CONCLUSION: High incidence of intravenous immunoglobulin-refractory KD may occur in up to 40% of the patients having recent history of coronavirus disease 2019. For patients having KD with N-type SARS-CoV-2 antibody positivity, adjunctive treatment, such as corticosteroids, can be considered as the first line of treatment.PMID:37337806 | PMC:PMC10279516 | DOI:10.3346/jkms.2023.38.e181

Source: Journal of Korean Medical Science - June 20, 2023 Category: Biomedical Science Authors: Jin Ho Kim Jihye You Source Type: research